Viridian Therapeutics, Inc./DE Investing Cash Flow
Viridian Therapeutics, Inc./DE (VRDN) reported Investing Cash Flow of -$153.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- Viridian Therapeutics, Inc./DE net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$231.16M, a 405.29% decline year-over-year.
- Viridian Therapeutics, Inc./DE net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $77.26M, a 22.79% decline year-over-year.
- Viridian Therapeutics, Inc./DE net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$339.42M.
- Viridian Therapeutics, Inc./DE net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $126.08M.
- Viridian Therapeutics, Inc./DE net cash provided by (used in) investing activities for fiscal 2025 was -$37.56M.
- Viridian Therapeutics, Inc./DE net cash provided by (used in) investing activities for fiscal 2024 was -$228.65M.
- Viridian Therapeutics, Inc./DE net cash provided by (used in) investing activities for fiscal 2023 was -$94.25M.
- Viridian Therapeutics, Inc./DE net cash provided by (used in) investing activities for fiscal 2022 was -$115.13M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$231.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$153.90M 10-Q · filed 2026-08-06 | -$493.32M derived: sum of 3 quarters · filed 2026-08-06 | -$367.24M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $77.26M 10-Q · filed 2026-05-05 | -$262.16M derived: sum of 2 quarters · filed 2026-05-05 | -$136.08M derived: sum of 3 quarters · filed 2026-05-05 | -$60.36M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$339.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$213.34M derived: sum of 2 quarters · filed 2026-02-26 | -$137.63M derived: sum of 3 quarters · filed 2026-08-06 | -$37.56M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $126.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $201.79M derived: sum of 2 quarters · filed 2026-08-06 | $301.86M 10-Q · filed 2025-11-05 | $238.94M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $75.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $175.78M 10-Q · filed 2026-08-06 | $112.86M derived: sum of 3 quarters · filed 2026-08-06 | $28.20M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $100.06M 10-Q · filed 2026-05-05 | $37.15M derived: sum of 2 quarters · filed 2026-05-05 | -$47.52M derived: sum of 3 quarters · filed 2026-05-05 | $14.46M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$62.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$147.58M derived: sum of 2 quarters · filed 2026-02-26 | -$85.61M derived: sum of 3 quarters · filed 2026-02-26 | -$228.65M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$84.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$22.69M derived: sum of 2 quarters · filed 2025-11-05 | -$165.74M 10-Q · filed 2025-11-05 | -$335.45M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $61.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$81.07M 10-Q · filed 2025-08-06 | -$250.78M derived: sum of 3 quarters · filed 2026-02-26 | -$202.74M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$143.04M 10-Q · filed 2025-05-06 | -$312.76M derived: sum of 2 quarters · filed 2026-02-26 | -$264.71M derived: sum of 3 quarters · filed 2026-02-26 | -$224.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$169.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$121.67M derived: sum of 2 quarters · filed 2026-02-26 | -$80.96M derived: sum of 3 quarters · filed 2026-02-26 | -$94.25M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $48.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $88.75M derived: sum of 2 quarters · filed 2024-11-12 | $75.46M 10-Q · filed 2024-11-12 | -$105.14M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $40.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $27.42M 10-Q · filed 2024-08-08 | -$153.19M derived: sum of 3 quarters · filed 2025-03-03 | -$110.53M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | -$13.29M 10-Q · filed 2024-05-08 | -$193.90M derived: sum of 2 quarters · filed 2025-03-03 | -$151.25M derived: sum of 3 quarters · filed 2025-03-03 | -$137.28M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | -$180.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$137.95M derived: sum of 2 quarters · filed 2025-03-03 | -$123.99M derived: sum of 3 quarters · filed 2025-03-03 | -$115.13M 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $42.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $56.61M derived: sum of 2 quarters · filed 2023-11-13 | $65.48M 10-Q · filed 2023-11-13 | -$14.73M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-06-30 | $13.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $22.83M 10-Q · filed 2023-08-08 | -$57.38M derived: sum of 3 quarters · filed 2024-02-27 | -$51.13M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-03-31 | $8.86M 10-Q · filed 2023-05-10 | -$71.35M derived: sum of 2 quarters · filed 2024-02-27 | -$65.10M derived: sum of 3 quarters · filed 2024-02-27 | -$76.30M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | -$80.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$73.96M derived: sum of 2 quarters · filed 2024-02-27 | -$85.16M derived: sum of 3 quarters · filed 2024-02-27 | -$74.29M 10-K · filed 2024-02-27 | ||||
| 2021-09-30 | $6.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$4.95M derived: sum of 2 quarters · filed 2022-11-14 | $5.92M 10-Q · filed 2022-11-14 | -$46.51M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$11.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$333.00K 10-Q · filed 2022-08-15 | -$52.76M derived: sum of 3 quarters · filed 2022-08-15 | -$52.81M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $10.87M 10-Q · filed 2022-05-13 | -$41.56M derived: sum of 2 quarters · filed 2022-05-13 | -$41.61M derived: sum of 3 quarters · filed 2022-05-13 | -$41.61M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$52.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$52.48M derived: sum of 2 quarters · filed 2022-03-11 | -$52.48M derived: sum of 3 quarters · filed 2022-03-11 | -$50.48M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | -$53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$53.00K derived: sum of 2 quarters · filed 2021-11-05 | $1.95M 10-Q · filed 2021-11-05 | $8.95M derived: sum of 4 quarters · filed 2021-11-05 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.00M 10-Q · filed 2021-08-12 | $9.00M derived: sum of 3 quarters · filed 2021-08-12 | $20.02M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $2.00M 10-Q · filed 2021-05-07 | $9.00M derived: sum of 2 quarters · filed 2021-05-07 | $20.02M derived: sum of 3 quarters · filed 2021-05-07 | $33.05M derived: sum of 4 quarters · filed 2021-05-07 | ||||
| 2019-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $18.02M derived: sum of 2 quarters · filed 2021-03-26 | $31.05M derived: sum of 3 quarters · filed 2021-03-26 | $28.23M 10-K · filed 2021-03-26 | ||||
| 2019-09-30 | $11.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $24.05M derived: sum of 2 quarters · filed 2020-11-12 | $21.23M 10-Q · filed 2020-11-12 | $30.32M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $13.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $10.21M 10-Q · filed 2020-08-05 | $19.30M derived: sum of 3 quarters · filed 2020-08-05 | $13.28M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | -$2.82M 10-Q · filed 2020-05-08 | $6.27M derived: sum of 2 quarters · filed 2020-05-08 | $257.00K derived: sum of 3 quarters · filed 2020-05-08 | -$32.63M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $9.09M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $3.08M derived: sum of 2 quarters · filed 2020-03-13 | -$29.81M derived: sum of 3 quarters · filed 2020-03-13 | -$29.91M 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | -$6.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$38.90M derived: sum of 2 quarters · filed 2019-11-08 | -$39.00M 10-Q · filed 2019-11-08 | -$39.03M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | -$32.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$32.98M 10-Q · filed 2019-08-08 | -$33.02M derived: sum of 3 quarters · filed 2019-08-08 | -$33.08M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$95.00K 10-Q · filed 2019-05-09 | -$129.00K derived: sum of 2 quarters · filed 2019-05-09 | -$192.00K derived: sum of 3 quarters · filed 2019-05-09 | -$297.00K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$97.00K derived: sum of 2 quarters · filed 2019-03-14 | -$202.00K derived: sum of 3 quarters · filed 2019-03-14 | $1.03M 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | -$63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$168.00K derived: sum of 2 quarters · filed 2018-11-07 | $1.07M 10-Q · filed 2018-11-07 | $2.07M derived: sum of 4 quarters · filed 2018-11-07 | ||||
| 2017-06-30 | -$105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $1.13M 10-Q · filed 2018-08-08 | $2.13M derived: sum of 3 quarters · filed 2018-08-08 | $5.11M derived: sum of 4 quarters · filed 2018-08-08 | ||||
| 2017-03-31 | $1.24M 10-Q · filed 2018-05-09 | $2.24M derived: sum of 2 quarters · filed 2018-05-09 | $5.21M derived: sum of 3 quarters · filed 2018-05-09 | $1.09M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2016-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $3.98M derived: sum of 2 quarters · filed 2018-03-15 | -$145.00K derived: sum of 3 quarters · filed 2018-03-15 | -$250.00K 10-K · filed 2018-03-15 | -$3.00K 10-K · filed 2017-03-24 | |||
| 2016-09-30 | $2.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$1.15M derived: sum of 2 quarters · filed 2017-11-09 | -$1.25M 10-Q · filed 2017-11-09 | -$3.00K 10-Q · filed 2016-10-26 | -$1.27M derived: sum of 4 quarters · filed 2017-11-09 | |||
| 2016-06-30 | -$4.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$4.22M 10-Q · filed 2017-08-11 | -$3.00K 10-Q · filed 2016-08-15 | -$4.25M derived: sum of 3 quarters · filed 2017-08-11 | -$4.25M derived: sum of 4 quarters · filed 2017-08-11 | |||
| 2016-03-31 | -$105.00K 10-Q · filed 2017-05-11 | -$3.00K 10-Q · filed 2016-05-16 | -$128.00K derived: sum of 2 quarters · filed 2017-05-11 | -$132.00K derived: sum of 3 quarters · filed 2017-05-11 | -$156.00K derived: sum of 4 quarters · filed 2017-05-11 | |||
| 2015-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | -$27.00K derived: sum of 2 quarters · filed 2017-03-24 | -$51.00K derived: sum of 3 quarters · filed 2017-03-24 | -$95.00K 10-K · filed 2017-03-24 | ||||
| 2015-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | -$28.00K derived: sum of 2 quarters · filed 2016-10-26 | -$72.00K 10-Q · filed 2016-10-26 | -$333.00K derived: sum of 4 quarters · filed 2016-10-26 | ||||
| 2015-06-30 | -$24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$68.00K 10-Q · filed 2016-08-15 | -$329.00K derived: sum of 3 quarters · filed 2016-08-15 | -$338.00K derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | -$44.00K 10-Q · filed 2016-05-16 | -$305.00K derived: sum of 2 quarters · filed 2016-05-16 | -$314.00K derived: sum of 3 quarters · filed 2016-05-16 | |||||
| 2014-12-31 | -$261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | -$270.00K derived: sum of 2 quarters · filed 2016-03-21 | -$274.00K 10-K · filed 2016-03-21 | |||||
| 2014-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$13.00K 10-Q · filed 2015-11-13 | -$12.62K 10-Q · filed 2014-11-14 | |||||
| 2014-06-30 | -$4.00K 10-Q · filed 2015-08-14 | -$4.29K 10-Q · filed 2014-08-14 | ||||||
| 2013-12-31 | -$2.33K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | -$4.50K derived: sum of 2 quarters · filed 2015-03-27 | $6.00K 10-K · filed 2015-03-27 | |||||
| 2013-09-30 | -$2.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $8.33K 10-Q · filed 2014-11-14 | ||||||
| 2013-06-30 | $10.50K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |